Cargando…

Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells

Statins have been shown to improve survival of metastatic prostate cancer (mPCa). Nevertheless, their therapeutic use is still under debate. In the present study, we investigated the short-term effects of three different statins (simvastatin, atorvastatin and rosuvastatin) in various PCa cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kafka, Mona, Gruber, Rebecca, Neuwirt, Hannes, Ladurner, Michael, Eder, Iris E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855777/ https://www.ncbi.nlm.nih.gov/pubmed/36672537 http://dx.doi.org/10.3390/biomedicines11010029

Ejemplares similares

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
por: Ladurner, Michael, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture
por: Eder, Theresa, et al.
Publicado: (2016)

Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells
por: Weber, Anja, et al.
Publicado: (2018)

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo
por: Ofer, Philipp, et al.
Publicado: (2015)

Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
por: Neuwirt, Hannes, et al.
Publicado: (2020)

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
por: Puhr, Martin, et al.
Publicado: (2014)

Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy
por: Neuwirt, Hannes, et al.
Publicado: (2019)

IL-6-mediated migration of human metastatic melanoma cells is reduced by simvastatin treatment
por: Wasinger, Christine, et al.
Publicado: (2012)

Enhanced Inhibition of Prostate Tumor Growth by Dual Targeting the Androgen Receptor and the Regulatory Subunit Type Iα of Protein Kinase A in Vivo
por: Eder, Iris E., et al.
Publicado: (2013)

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
por: Chen, Yu-An, et al.
Publicado: (2018)

Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response
por: Kafka, Mona, et al.
Publicado: (2022)

Effect of simvastatin on castration-resistant prostate cancer cells
por: Kim, Jenny Hanbi, et al.
Publicado: (2014)

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
por: Bardini, Gianluca, et al.
Publicado: (2010)

Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin
por: Korte, Verena, et al.
Publicado: (2022)

Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
por: Chen, Mei-Chieh, et al.
Publicado: (2017)

Simvastatin Downregulates Cofilin and Stathmin to Inhibit Skeletal Muscle Cells Migration
por: Lin, Li-Ping, et al.
Publicado: (2022)

In Reply to ‘Do SGLT-2 Inhibitors Act Only Through a Functional Tubuloglomerular Feedback Induced by the Increased Outflow of Sodium?’
por: Neuwirt, Hannes, et al.
Publicado: (2020)

Simvastatin reduces melanoma progression in a murine model
por: ZANFARDINO, MARIO, et al.
Publicado: (2013)

Simvastatin Reduces Capsular Fibrosis around Silicone Implants
por: Chung, Kyu Jin, et al.
Publicado: (2016)

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
por: Dias, Irundika H.K., et al.
Publicado: (2018)

Recent Insights on Genetic Testing in Primary Prostate Cancer
por: Kafka, Mona, et al.
Publicado: (2021)

Akacid Medical Formulation Induces Apoptosis in Myeloid and Lymphatic Leukemic Cell Lines In Vitro and In Vivo
por: Neuwirt, Hannes, et al.
Publicado: (2015)

Simvastatin provides long‐term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy
por: Kim, Min J., et al.
Publicado: (2019)

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
por: Wolozin, Benjamin, et al.
Publicado: (2007)

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
por: Dhakal, Sudip, et al.
Publicado: (2019)

Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis
por: Wang, Fengjiao, et al.
Publicado: (2018)

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin
por: Mak, Blossom, et al.
Publicado: (2022)

Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report
por: Frydrychowicz, Clara, et al.
Publicado: (2017)

Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?
por: Staudacher, Nina, et al.
Publicado: (2020)

Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
por: Dillon, Hayley T., et al.
Publicado: (2023)

Simvastatin versus triptorelin in prevention of pain recurrences after surgery for endometriosis
por: Kargar, Mona, et al.
Publicado: (2013)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
por: Bösmüller, Claudia, et al.
Publicado: (2019)

Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis
por: Goc, Anna, et al.
Publicado: (2012)

Simvastatin enhances irinotecan-induced apoptosis in prostate cancer via inhibition of MCL-1
por: Alqudah, Mohammad A.Y., et al.
Publicado: (2018)

Discontinuation of simvastatin leads to a rebound phenomenon and results in immediate peri‐implant bone loss
por: Li, Xianqi, et al.
Publicado: (2016)

Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk—A Single Center Experience
por: Neuwirt, Hannes, et al.
Publicado: (2019)

Erratum: Correction of Figure: Simvastatin Reduces Capsular Fibrosis around Silicone Implants
por: Chung, Kyu Jin, et al.
Publicado: (2016)

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression
por: Chen, Yun-Rong, et al.
Publicado: (2023)

Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity
por: Pecoraro, Michela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruuq3g1sc6q75kc4iobucstnn3